Mechanism of antimicrobial action
The target for oxazolidinones is the process of protein synthesis in the bacterial cell, specifically the functioning of ribosomes. Linezolid has a specific point of action: it binds to the P-site of the 50S subunit of the bacterial ribosome. As a result of this interaction, the earliest stage of translation is blocked—the formation of the initiation complex consisting of the ribosome and fMet-tRNA.
The clinical significance of this mechanism is enormous. Because the point of action is completely unique, bacteria do not develop cross-resistance between oxazolidinones and other known protein synthesis inhibitors. The drug retains efficacy where macrolides, aminoglycosides, tetracyclines, lincosamides, and chloramphenicol are powerless. Resistance to linezolid itself develops extremely slowly and is associated with a mutation in the 23S ribosomal RNA.
Spectrum of activity and type of action
The main spectrum of activity of the drug covers Gram-positive flora. The drug is a reserve agent for the treatment of infections caused by multiresistant strains:
- MRSA (methicillin-resistant Staphylococcus aureus);
- Penicillin-resistant streptococci;
- VRE (vancomycin-resistant enterococci and staphylococci).
According to the type of antimicrobial action, linezolid is a bacteriostatic agent—it stops the growth and reproduction of bacteria. However, there are important exceptions to this rule. The drug acts bactericidally (kills the cell) against anaerobic flora (Bacteroides fragilis, Clostridium perfringens) and certain streptococcal species (S. pneumoniae, S. pyogenes).
Pharmacokinetics and indications for use
The drug has absolute bioavailability (100%), meaning it is completely absorbed when taken orally. This allows it to be used both intravenously and orally with equal efficacy. The dosing regimen is standard—every 12 hours.
Oxazolidinones are distinguished by high penetrative capacity. They achieve therapeutic concentrations in virtually all tissues and body fluids, including skin, lungs, heart, central nervous system (CNS), bones, and synovial fluid.
Main indications include:
- Community-acquired and hospital-acquired pneumonia (important: if Gram-negative flora is suspected, combination with other antibiotics is strictly required).
- Skin and soft tissue infections.
- Any infections caused by vancomycin-resistant enterococci.
Side effects and drug interactions
Despite high efficacy, therapy requires careful monitoring due to a wide range of adverse reactions:
- Blood system: reversible bone marrow suppression may occur, manifesting as thrombocytopenia, anemia, leukopenia, or pancytopenia.
- Gastrointestinal tract: dyspeptic disorders (nausea, diarrhea), taste alterations, and specific tongue discoloration.
- Nervous system: headache. With prolonged courses (over 8 weeks), the risk of peripheral neuropathy and optic neuropathy increases.
- Other: skin rash and metabolic disturbances (lactic acidosis).
A pharmacological feature of linezolid is that it acts as a reversible non-selective monoamine oxidase inhibitor (MAOI). This creates serious clinical risks when interacting with other drugs. When combined with adrenomimetics (adrenaline, dopamine) or serotonin reuptake inhibitors, severe complications can develop: tachycardia, severe headache, hypertensive crisis, and a life-threatening condition—serotonin syndrome.
Briefly: answers to topical questions
What are the contraindications for the use of linezolid?
The main contraindications to the use of linezolid are hypersensitivity and age restrictions for certain dosage forms.
- Hypersensitivity serves as a general absolute contraindication to the prescription of antibacterial drugs of this group.
- Children under 12 years of age—the use of tablet forms of linezolid is strictly contraindicated for this category of patients.
Is a dose adjustment of linezolid required in severe renal impairment?
Dose adjustment of linezolid in severe renal impairment is not required. The drug belongs to the group of antibacterial agents that do not need a change in the standard dosing regimen when renal function decreases. Linezolid can be safely used in patients with renal impairment, as well as with concomitant liver disease.
To quickly memorize the spectrum of activity of linezolid, use the abbreviation MVP (main targets of the drug): M — MRSA (methicillin-resistant Staphylococcus), V — VRE (vancomycin-resistant enterococci), P — Penicillin-resistant streptococci.
Class and exam questions
Why doesn't cross-resistance occur between linezolid and macrolides or tetracyclines?
This is due to the unique target. Linezolid binds to the P-site of the 50S ribosomal subunit and blocks the formation of the initiation complex with fMet-tRNA. Other protein synthesis inhibitors act at later stages of translation.
Do oxazolidinones always act solely as bacteriostatic agents?
No, by default these are bacteriostatic drugs, but they exhibit bactericidal action against anaerobes (e.g., Bacteroides fragilis, Clostridium perfringens) and certain streptococci (S. pneumoniae, S. pyogenes).
What is the main danger of using linezolid concomitantly with antidepressants?
Linezolid is a reversible non-selective MAO inhibitor. Simultaneous administration with drugs affecting serotonin uptake sharply increases the risk of developing life-threatening serotonin syndrome, hypertensive crisis, and tachycardia.
How does the bioavailability of the drug affect the choice of administration route?
The bioavailability of linezolid is 100%. This means that the drug is completely absorbed in the gastrointestinal tract, and its concentration in the blood when taken orally is the same as with intravenous administration. This allows patients to be easily switched from drips to pills without loss of efficacy.
What else to study on this topic
- Mechanisms of development and clinical picture of serotonin syndrome during antibiotic therapy.
- Hematological toxicity: algorithms for monitoring blood counts during prolonged administration.
- 23S ribosomal RNA mutation as the main pathway for bacteria to escape drug action.
- Rationale for combination therapy in hospital-acquired pneumonia of mixed etiology.
- Risks of peripheral and optic neuropathy during treatment courses exceeding 8 weeks.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Oxazolidinones" and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Antibacterial Chemotherapeutic Agents"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.